USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
Work
Year: 2023
Type: article
Abstract: SREBP2 is a master regulator of the mevalonate pathway (MVP), a biosynthetic process that drives the synthesis of dolichol, heme A, ubiquinone and cholesterol and also provides substrates for protein ... more
Source: Cell Death and Differentiation
Authors Carina R. Maier, Oliver Hartmann, Cristian Prieto‐Garcia, Kamal M. Al-Shami, Lisa Schlicker +14 more
Institutions Heidelberg University, German Cancer Research Center, Goethe University Frankfurt, Comprehensive Cancer Center Mainfranken, University of Würzburg +2 more
Cites: 57
Cited by: 15
Related to: 10
FWCI: 2.914
Citation percentile (by year/subfield): 100
Subfield: Molecular Biology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $5,290
Funders Deutscher Akademischer Austauschdienst, Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe
Grant IDS 91559476, GRK 2243, 70114554